AU2016256637A1 - Composition containing norbixin for protecting cells of the retinal pigment epithelium - Google Patents

Composition containing norbixin for protecting cells of the retinal pigment epithelium Download PDF

Info

Publication number
AU2016256637A1
AU2016256637A1 AU2016256637A AU2016256637A AU2016256637A1 AU 2016256637 A1 AU2016256637 A1 AU 2016256637A1 AU 2016256637 A AU2016256637 A AU 2016256637A AU 2016256637 A AU2016256637 A AU 2016256637A AU 2016256637 A1 AU2016256637 A1 AU 2016256637A1
Authority
AU
Australia
Prior art keywords
norbixin
composition
cells
bixin
rpe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016256637A
Other languages
English (en)
Inventor
Pierre-Paul Elena
Valérie FONTAINE
René LAFONT
José-Alain Sahel
Stanislas Veillet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Pierre et Marie Curie
Biophytis SA
Original Assignee
Universite Pierre et Marie Curie
Biophytis SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Pierre et Marie Curie, Biophytis SA filed Critical Universite Pierre et Marie Curie
Publication of AU2016256637A1 publication Critical patent/AU2016256637A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/30Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
AU2016256637A 2015-04-30 2016-04-28 Composition containing norbixin for protecting cells of the retinal pigment epithelium Abandoned AU2016256637A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1553957 2015-04-30
FR1553957A FR3035589B1 (fr) 2015-04-30 2015-04-30 Composition pour la protection des cellules de l'epithelium pigmentaire retinien
PCT/FR2016/051001 WO2016174360A1 (fr) 2015-04-30 2016-04-28 Composition contenant de la norbixine pour la protection des cellules de l'epithelium pigmentaire retinien

Publications (1)

Publication Number Publication Date
AU2016256637A1 true AU2016256637A1 (en) 2017-12-14

Family

ID=53758384

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016256637A Abandoned AU2016256637A1 (en) 2015-04-30 2016-04-28 Composition containing norbixin for protecting cells of the retinal pigment epithelium

Country Status (15)

Country Link
US (1) US10314804B2 (enExample)
EP (1) EP3288551B1 (enExample)
JP (1) JP6660401B2 (enExample)
KR (1) KR102575312B1 (enExample)
CN (1) CN107708685B (enExample)
AU (1) AU2016256637A1 (enExample)
BR (1) BR112017023264A2 (enExample)
CA (1) CA2984405C (enExample)
ES (1) ES2752061T3 (enExample)
FR (1) FR3035589B1 (enExample)
IL (1) IL255276A0 (enExample)
MX (1) MX376021B (enExample)
PL (1) PL3288551T3 (enExample)
RU (1) RU2715889C2 (enExample)
WO (1) WO2016174360A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3078252B1 (fr) * 2018-02-28 2020-08-14 Biophytis Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation
CA3098868A1 (en) 2018-05-03 2019-11-07 L.E.A.F. Holdings Group Llc Carotenoid compositions and uses thereof
KR20200134935A (ko) 2019-05-24 2020-12-02 (주)비지엔케어 커큐민을 유효성분으로 포함하는 인간 망막색소상피세포 증식 개선용 약학 조성물
EP4054637A4 (en) * 2019-11-06 2023-12-20 L.E.A.F Holdings Group LLC CAROTINOID COMPOSITIONS AND USES THEREOF
FR3105790B1 (fr) * 2019-12-26 2022-01-14 Biophytis Composés chimiques ciblant l’œil et leur utilisation dans le traitement de maladies oculaires
KR20210008884A (ko) 2021-01-08 2021-01-25 (주)비지엔케어 커큐민을 유효성분으로 포함하는 인간 망막색소상피세포 증식 개선용 조성물 및 기능성 식품 조성물
TWI894483B (zh) * 2022-08-24 2025-08-21 鼎赫生物科技股份有限公司 一種組合物用於治療眼睛疾病之醫藥品用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1154172A (fr) 1955-07-05 1958-04-03 Rollei Werke Franke Heidecke étui de protection pour appareils photographiques
WO2001085183A2 (en) * 2000-05-08 2001-11-15 N.V. Nutricia Preparation for the prevention and treatment of ocular disorders
CA2528718A1 (en) * 2003-06-20 2004-12-29 Alcon, Inc. Treatment of amd with combination of ingredients
US7887847B2 (en) * 2004-05-08 2011-02-15 Paul Jr Edward L Nutritional supplement for treatment of ocular diseases
EP1814540A2 (en) * 2004-11-16 2007-08-08 Nu-Tein Co., Inc. Compositions useful to treat ocular neovascular diseases and macular degeneration
JP2008179632A (ja) * 2006-12-29 2008-08-07 Fuji Chem Ind Co Ltd 抗酸化剤
JP5550854B2 (ja) * 2009-06-10 2014-07-16 理研ビタミン株式会社 一重項酸素消去剤
FR2947173B1 (fr) 2009-06-25 2012-01-27 Inst Biophytis Composition alimentaire destinee a la protection solaire
JP2012097003A (ja) * 2010-10-29 2012-05-24 Gifu City ビキシン誘導体及び細胞保護剤
FR2975008B1 (fr) * 2011-05-13 2014-03-07 Inst Biophytis Utilisation de composes et composition pour le traitement de la degenerescence maculaire liee a l'age (dmla)

Also Published As

Publication number Publication date
CA2984405C (fr) 2024-01-23
IL255276A0 (en) 2017-12-31
ES2752061T3 (es) 2020-04-02
PL3288551T3 (pl) 2020-04-30
CA2984405A1 (fr) 2016-11-03
JP6660401B2 (ja) 2020-03-11
FR3035589A1 (fr) 2016-11-04
JP2018518460A (ja) 2018-07-12
KR102575312B1 (ko) 2023-09-06
BR112017023264A2 (pt) 2018-08-07
RU2017141462A (ru) 2019-05-31
US20180289651A1 (en) 2018-10-11
MX2017013918A (es) 2018-04-24
EP3288551A1 (fr) 2018-03-07
US10314804B2 (en) 2019-06-11
CN107708685B (zh) 2021-09-21
RU2715889C2 (ru) 2020-03-04
EP3288551B1 (fr) 2019-07-31
WO2016174360A9 (fr) 2017-11-16
RU2017141462A3 (enExample) 2019-09-12
CN107708685A (zh) 2018-02-16
FR3035589B1 (fr) 2019-12-13
WO2016174360A1 (fr) 2016-11-03
KR20180011777A (ko) 2018-02-02
MX376021B (es) 2025-03-07

Similar Documents

Publication Publication Date Title
US10314804B2 (en) Composition containing norbixin for protecting cells of the retinal pigment epithelium
KR101660195B1 (ko) 크릴 오일과 반응한 아스타잔틴 조성물 및 관련 방법
EP2717891B1 (fr) Composition de bixa orellana pour le traitement de la dégénérescence maculaire
CN106163536A (zh) 亲脂性营养素对糖尿病性眼病的作用
US9351982B2 (en) Krill oil and reacted astaxanthin composition and associated method
WO2017135466A1 (ja) キサントフィルとヒシ属植物の加工物を含有する組成物
Akkewar et al. A mechanistic review on growing multiple therapeutic applications of lutein and its global market research
JP6148780B1 (ja) キサントフィルとヒシ属植物の加工物を含有する組成物
Zhao et al. Advances in research on natural distribution, biosynthesis, detection, bioactivity, and application of lutein
Ketsutham et al. Herb-derived Compounds and Other Potential Molecules for Non-exudative Age-related Macular Degeneration (AMD): A Systematic Review.
Yoshizawa et al. N-methyl-N-nitrosourea-induced retinal degeneration in rats: a reliable animal model of retinitis pigmentosa for the development of new therapeutic strategies
Zuo et al. Anthocyanin-Rich Berries and Their Bioactive Compounds in Ocular Health: Mechanisms and Therapeutic Potential
STUDIES et al. Asian Journal of Phytomedicine and Clinical Research

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period